DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in DMK Pharmaceuticals Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q2 2023
- Shares held
- 259.2K
- +144.4K (+125.8%) vs. Q2 2023
- Total value
- $178.7K
- −$97.5K (−35.3%) vs. Q2 2023
- New holders
- 6
- 4 more added
- Sold out
- 2
- 3 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 3 | $4 |
| Q4 2023 | 29 | $350.4K |
| Q3 2023 | 25 | $178.7K |
| Q2 2023 | 22 | $276.4K |
| Q1 2023 | 47 | $3.20M |
| Q4 2022 | 48 | $2.16M |
| Q3 2022 | 43 | $2.55M |
| Q2 2022 | 45 | $6.44M |
| Q1 2022 | 46 | $7.38M |
| Q4 2021 | 49 | $8.58M |
| Q3 2021 | 53 | $14.6M |
| Q2 2021 | 51 | $17.8M |
| Q1 2021 | 53 | $11.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding DMK Pharmaceuticals Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 54,042 | $37.2K | 0.00% | +35,095+185.2% | Added |
| BlackRock Inc. | 39,530 | $27.2K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 34,706 | $23.9K | 0.00% | +33,022+1,960.9% | Added |
| Vanguard Group Inc | 30,090 | $20.7K | 0.00% | −820−2.7% | Reduced |
| Two Sigma Securities, LLC | 29,708 | $20.5K | 0.00% | +29,708 | New |
| Tower Research Capital LLC (TRC) | 24,043 | $16.6K | 0.00% | +17,071+244.9% | Added |
| Virtu Financial LLC | 18,719 | $13.0K | 0.00% | +18,719 | New |
| StoneX Group Inc. | 13,258 | $9.13K | 0.00% | +13,258 | New |
| XTX Topco Ltd | 12,024 | $8.29K | 0.00% | +12,024 | New |
| Morgan Stanley | 1,342 | $925 | 0.00% | −18−1.3% | Reduced |
| Bank of America Corp | 561 | $386 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 203 | $140 | 0.00% | +44+27.7% | Added |
| UBS Group AG | 192 | $132 | 0.00% | −94−32.9% | Reduced |
| Harbour Investments, Inc. | 183 | $126 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 151 | $105 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 100 | $69 | 0.00% | +100 | New |
| Group One Trading, L.P. | 94 | $65 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 87 | $60 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 50 | $35 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 38 | $26 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 28 | $19 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 12 | $8 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 7 | $5 | 0.00% | +7 | New |
| Cape Investment Advisory, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Winch Advisory Services, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,655−100.0% | Sold out |
| Founders Capital Management | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Coastal Capital Group, Inc. | – | – | – | – | Not filed |